GALMOZZI, ENRICO
GALMOZZI, ENRICO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Hepatic fat - genetic risk score predicts hepatocellular carcinoma in HCV cirrhotic patients treated with DAAs
2020 E. Degasperi, E. Galmozzi, S. Pelusi, R. D'Ambrosio, R. Soffredini, M. Borghi, R. Perbellini, F. Facchetti, M. Iavarone, A. Sangiovanni, L. Valenti, P. Lampertico
TLL1 Variants do not predict hepatocellular carcinoma development in hcv cirrhotic patients treated with direct-acting antivirals
2019 E. Degasperi, E. Galmozzi, F. Facchetti, E. Farina, R. D'Ambrosio, R. Soffredini, M. Iavarone, P. Lampertico
Tenofovir alafenamide as a rescue therapy in a patient with HBV-cirrhosis with a history of Fanconi syndrome and multidrug resistance
2018 G. Glenda, A. Loglio, F. Facchetti, B. Marta, R.M. Soffredini, E. Galmozzi, L. Giovanna, G. Anuj, P. Lampertico
IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients
2018 E. Galmozzi, F. Facchetti, G. Glenda, A. Loglio, M. Vigano', L. Giovanna, M.G. Colombo, P. Lampertico
Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B
2017 F. Lebossé, B. Testoni, J. Fresquet, F. Facchetti, E. Galmozzi, M. Fournier, V. Hervieu, P. Berthillon, F. Berby, I. Bordes, D. Durantel, M. Levrero, P. Lampertico, F. Zoulim
Systematic review with meta-analysis : do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection?
2014 E. Galmozzi, M. Viganò, P. Lampertico
The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent
2014 R. D'Ambrosio, A. Aghemo, R. De Francesco, M.G. Rumi, E. Galmozzi, S. De Nicola, C. Cheroni, P.J. Clark, G. Ronchi, P. Lampertico, M. Colombo
Letter: Do interferon lambda 3 polymorphisms predict the outcome of interferon therapy in hepatitis B infection? Authors' reply
2014 E. Galmozzi, M. Viganò, P. Lampertico
Limited utility of ITPA deficiency to predict early anemia in HCV patients with advanced fibrosis receiving telaprevir
2014 A. Aghemo, E. Grassi, M.G. Rumi, R. D'Ambrosio, E. Galmozzi, E. Degasperi, D. Castaldi, R. Soffredini, M. Colombo
Letter: Does the IFNL4 gene discovery really provide a causal role for the IL28B haplotype blocks?
2014 E. Galmozzi, P. Lampertico
Studies of IL28B genotype and response to peginterferon in chronic hepatitis B should be stratified by HBV genotype
2013 P. Lampertico, E. Galmozzi, M. Colombo
Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patients
2013 A. Aghemo, E. Degasperi, M.G. Rumi, E. Galmozzi, L. Valenti, R. De Francesco, S. De Nicola, C. Cheroni, E. Grassi, M. Colombo
Allelic inhibition of displacement activity : a simplified one tube allele-specific PCR for evaluation of ITPA polymorphisms
2013 E. Galmozzi, F. Facchetti, E. Degasperi, A. Aghemo, P. Lampertico
Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy
2013 P.J. Clark, A. Aghemo, E. Degasperi, E. Galmozzi, T.J. Urban, D.M. Vock, K. Patel, A.J. Thompson, M.G. Rumi, R. D'Ambrosio, A.J. Muir, M. Colombo
Genetic testing for hepatocellular carcinoma : an ambitious goal still to achieve
2012 E. Galmozzi, M. Colombo
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4
2012 S. De Nicola, A. Aghemo, M. Rumi, E. Galmozzi, L. Valenti, R. Soffredini, R. De Francesco, G. Prati, R. D'Ambrosio, C. Cheroni, M.F. Donato, M. Colombo
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype
2011 R. Rametta, E. Canavesi, M. Ruscica, A.L. Fracanzani, P. Dongiovanni, E. Galmozzi, P. Magni, S.R. Fargion, L.V.C. Valenti
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype
2011 L.V.C. Valenti, R. Rametta, E. Canavesi, M. Ruscica, A.L. Fracanzani, P. Dongiovanni, E. Galmozzi, P. Magni, S.R. Fargion
A tetra-primer amplification refractory mutation system polymerase chain reaction for the evaluation of rs12979860 IL28B genotype
2011 E. Galmozzi, B. Del Menico, R. Rametta, P. Dongiovanni, A. L. Fracanzani, L. Benedan, V. Borroni, P. Maggioni, S. R. Fargion, L. V. C. Valenti
Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C
2011 L.V.C. Valenti, M. Rumi, E. Galmozzi, A.M. Aghemo, B. Del Menico, S. De Nicola, P. Dongiovanni, M. Maggioni, A.L. Fracanzani, R. Rametta, M. Colombo, S.R. Fargion